While stressing the data are preliminary and must undergo intensive review, Dr. Rick Malley, an infectious disease and vaccine specialist at Boston Children's Hospital and Harvard Medical School, says he's hopeful the vaccines showing early success will work well on a wide scale and help quell concerns over the rapid pace at which they are being developed.
↧